reimbursement

HUTCHMED Announces Continued Inclusion of ORPATHYS (savolitinib) in the National Reimbursement Drug List in China at CurrentTerms

November 28, 2024 05:30 ET | Source: HUTCHMED (China) Limited HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 28,…

3 weeks ago

HeartFlow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access

November 01, 2024 18:14 ET | Source: HeartFlow Holding, Inc. — Hospital Outpatient Prospective Payment System reimbursement rate doubled, expanding…

2 months ago